GKSL173.89

Gujarat Kidney And Super Speciality Limited

· Pharma & Health
₹ CrorePeersGPTHEALTHSHALBYINDRAMEDCOLOTUSEYEARTEMISMEDDRAGARWQKMCSHILKOVAIMcap ₹1,371 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY26
31/03/2026
Last 12M
30/06/2026
Non-current Assets
+ Property, Plant & Equipment27.027.0
+ Goodwill90.790.7
+ Other Intangibles10.810.8
+ Other Non-current Financial Assets2.92.9
Non-current Financial Assets2.92.9
+ Deferred Tax Assets2.52.5
+ Other Non-current Assets59.159.1
Total Non-current Assets193.1193.1
Current Assets
+ Inventories2.12.1
+ Trade Receivables38.638.6
+ Cash & Cash Equivalents13.313.3
+ Other Bank Balances43.043.0
+ Short-term Loans0.90.9
+ Other Current Financial Assets3.23.2
Current Financial Assets99.099.0
+ Other Current Assets2.02.0
Total Current Assets104.6104.6
Total Assets297.6297.6
Equity
+ Equity Share Capital15.815.8
+ Other Equity / Reserves236.7236.7
Equity — Owners of Parent252.5252.5
+ Minority Interest2.22.2
Total Equity254.7254.7
Liabilities
+ Borrowings — Non-current1.81.8
+ Other Non-current Financial Liab0.90.9
Non-current Financial Liabilities2.72.7
+ Other Non-current Liabilities12.412.4
Non-current Liabilities15.115.1
+ Borrowings — Current13.913.9
+ Trade Payables8.58.5
+ Other Current Financial Liab0.20.2
Current Financial Liabilities22.622.6
+ Provisions — Current0.20.2
+ Other Current Liabilities5.15.1
Current Liabilities27.827.8
Total Liabilities42.942.9
Total Equity & Liabilities297.6297.6
Assets — additional as-filed lines
+ Current Tax Assets1.61.6
Trade Payables — MSME split
+ Dues to Other Creditors — Current8.58.5
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.